{"id":1044,"date":"2026-07-03T09:01:15","date_gmt":"2026-07-03T09:01:15","guid":{"rendered":"https:\/\/isbm-blow-molding.com\/?p=1044"},"modified":"2026-07-03T09:01:15","modified_gmt":"2026-07-03T09:01:15","slug":"hdpe-eye-drop-bottle-ibm-korean-production-guide","status":"publish","type":"post","link":"https:\/\/isbm-blow-molding.com\/da\/hdpe-eye-drop-bottle-ibm-korean-production-guide\/","title":{"rendered":"HDPE \u00f8jendr\u00e5beflaske IBM: Koreansk produktionsvejledning"},"content":{"rendered":"<header style=\"position: relative; min-height: min(560px,84vh); display: flex; align-items: center; padding: clamp(40px,6vw,80px) clamp(18px,5vw,56px); box-sizing: border-box; width: 100%; background: #03111e; background-image: linear-gradient(150deg,rgba(2,8,18,0.97) 0%,rgba(4,18,38,0.94) 55%,rgba(3,105,161,0.28) 100%),url('https:\/\/isbm-blow-molding.com\/wp-content\/uploads\/2026\/07\/Injection-Blow-Molding-Machine-ZQ60.webp'); background-size: cover; background-position: center;\">\n<div style=\"max-width: 680px;\"><span style=\"display: inline-block; font-size: 10px; font-weight: bold; letter-spacing: 2.5px; text-transform: uppercase; color: #7dd3fc; border: 1px solid rgba(125,211,252,0.32); padding: 4px 12px; border-radius: 3px; margin-bottom: 18px;\">Oftalmisk IBM \u00b7 \u00d8jendr\u00e5beholder \u00b7 Koreansk KFDA \u00b7 Koreansk Ever-Power<\/span><\/p>\n<h1 style=\"font-size: clamp(24px,4.2vw,40px); font-weight: 900; color: #fff; line-height: 1.18; margin: 0 0 20px; letter-spacing: -0.5px;\">HDPE \u00f8jendr\u00e5beflaske IBM:<br \/>\nKoreansk produktionsguide<\/h1>\n<p style=\"font-size: clamp(14px,1.9vw,17px); color: #bae6fd; line-height: 1.7; margin: 0 0 28px; max-width: 560px;\">Koreanske 10 ml HDPE oftalmiske beholdere er det farmaceutiske IBM-format med det h\u00f8jeste volumen i Korea og et af de mest teknisk kr\u00e6vende: pr\u00e6cision for indgreb med dr\u00e5beh\u00e6tte p\u00e5 \u00b10,05 mm, gennemsigtighed ved p\u00e5fyldningsniveau p\u00e5 0,30-0,40 mm husv\u00e6g, KFDA-overholdelse af oftalmiske partikler og \u00e5rlige volumenkrav p\u00e5 flere hundrede millioner enheder, der placerer ZQ110- og ZQ135-maskinerne i centrum for den koreanske produktions\u00f8konomi inden for oftalmisk emballage.<\/p>\n<div style=\"display: flex; flex-wrap: wrap; gap: 8px;\"><span style=\"background: rgba(255,255,255,0.08); border: 1px solid rgba(255,255,255,0.18); color: #bae6fd; font-size: 11.5px; font-weight: 600; padding: 5px 14px; border-radius: 20px;\">10 ml \u00d8konomi for kavitetsm\u00e5ling<\/span><br \/>\n<span style=\"background: rgba(255,255,255,0.08); border: 1px solid rgba(255,255,255,0.18); color: #bae6fd; font-size: 11.5px; font-weight: 600; padding: 5px 14px; border-radius: 20px;\">Pr\u00e6cision p\u00e5 pipetteh\u00e6ttehals<\/span><br \/>\n<span style=\"background: rgba(255,255,255,0.08); border: 1px solid rgba(255,255,255,0.18); color: #bae6fd; font-size: 11.5px; font-weight: 600; padding: 5px 14px; border-radius: 20px;\">KFDA oftalmologisk kvalifikation<\/span><\/div>\n<p style=\"font-size: 11px; color: #38bdf8; margin: 22px 0 0;\">Korea Ever-Power Engineering Desk \u00b7 Ansan-si \u00b7 Juli 2026<\/p>\n<\/div>\n<\/header>\n<p>&nbsp;<\/p>\n<p><!-- KPI BAR --><\/p>\n<div style=\"background: #f0f9ff; border: 1px solid #bae6fd; border-radius: 8px; padding: 20px 24px; margin: 44px 0 0;\">\n<p style=\"font-size: 10.5px; font-weight: 800; letter-spacing: 2px; text-transform: uppercase; color: #0369a1; margin: 0 0 14px;\">Koreansk oftalmisk IBM \u2014 Referencedata<\/p>\n<div style=\"display: grid; grid-template-columns: repeat(auto-fit,minmax(min(100%,150px),1fr)); gap: 12px;\">\n<div style=\"background: #fff; border-radius: 6px; padding: 14px; border-top: 3px solid #0369a1; text-align: center;\">\n<p style=\"font-size: 22px; font-weight: 900; color: #0369a1; margin: 0 0 4px;\">10 ml<\/p>\n<p style=\"font-size: 12px; color: #374151; margin: 0; line-height: 1.4;\">Standard koreansk oftalmisk beholder \u2014 IBM-formatet med den h\u00f8jeste \u00e5rlige eftersp\u00f8rgsel<\/p>\n<\/div>\n<div style=\"background: #fff; border-radius: 6px; padding: 14px; border-top: 3px solid #0284c7; text-align: center;\">\n<p style=\"font-size: 22px; font-weight: 900; color: #0369a1; margin: 0 0 4px;\">500 millioner+<\/p>\n<p style=\"font-size: 12px; color: #374151; margin: 0; line-height: 1.4;\">Ansl\u00e5et \u00e5rlig koreansk eftersp\u00f8rgsel efter oftalmiske beholdere \u2014 kontaktlinser, t\u00f8rre \u00f8jne, receptpligtig<\/p>\n<\/div>\n<div style=\"background: #fff; border-radius: 6px; padding: 14px; border-top: 3px solid #0ea5e9; text-align: center;\">\n<p style=\"font-size: 22px; font-weight: 900; color: #0369a1; margin: 0 0 4px;\">\u00b10,05 mm<\/p>\n<p style=\"font-size: 12px; color: #374151; margin: 0; line-height: 1.4;\">IBM-hals OD-tolerance \u2014 indgreb med dropperh\u00e6tte kr\u00e6ver et vindue p\u00e5 \u00b10,06 mm<\/p>\n<\/div>\n<div style=\"background: #fff; border-radius: 6px; padding: 14px; border-top: 3px solid #38bdf8; text-align: center;\">\n<p style=\"font-size: 22px; font-weight: 900; color: #0369a1; margin: 0 0 4px;\">~23.800\/t<\/p>\n<p style=\"font-size: 12px; color: #374151; margin: 0; line-height: 1.4;\">ZQ135 ved 30 hulrum \u2014 h\u00f8jeste output fra en enkelt maskine fra Korea med oftalmologisk IBM<\/p>\n<\/div>\n<\/div>\n<\/div>\n<p><!-- TOC --><\/p>\n<nav style=\"margin: 32px 0 0; background: #f9fafb; border: 1px solid #e5e7eb; border-radius: 8px; padding: 20px 22px;\">\n<p style=\"font-size: 10.5px; font-weight: bold; text-transform: uppercase; letter-spacing: 1.5px; color: #374151; margin: 0 0 12px;\">Indhold<\/p>\n<div style=\"display: grid; grid-template-columns: repeat(auto-fit,minmax(min(100%,260px),1fr)); gap: 4px 20px;\"><a style=\"color: #0369a1; text-decoration: none; font-size: 14px; padding: 3px 0; display: block;\" href=\"#s1\">1. Korean Ophthalmic Market and IBM&#8217;s Role<\/a><br \/>\n<a style=\"color: #0369a1; text-decoration: none; font-size: 14px; padding: 3px 0; display: block;\" href=\"#s2\">2. Specifikationer for 10 ml HDPE oftalmisk beholder<\/a><br \/>\n<a style=\"color: #0369a1; text-decoration: none; font-size: 14px; padding: 3px 0; display: block;\" href=\"#s3\">3. IBM Neck Precision til indgreb med dropperh\u00e6tte<\/a><br \/>\n<a style=\"color: #0369a1; text-decoration: none; font-size: 14px; padding: 3px 0; display: block;\" href=\"#s4\">4. HDPE-kvalitet og forarbejdning til oftalmologisk IBM<\/a><br \/>\n<a style=\"color: #0369a1; text-decoration: none; font-size: 14px; padding: 3px 0; display: block;\" href=\"#s5\">5. Koreansk KFDA oftalmologisk kvalifikation<\/a><br \/>\n<a style=\"color: #0369a1; text-decoration: none; font-size: 14px; padding: 3px 0; display: block;\" href=\"#s6\">6. IBM renrumsops\u00e6tning til oftalmisk produktion<\/a><br \/>\n<a style=\"color: #0369a1; text-decoration: none; font-size: 14px; padding: 3px 0; display: block;\" href=\"#s7\">7. \u00d8konomi for kavitetsm\u00e5ling for koreansk oftalmisk IBM<\/a><br \/>\n<a style=\"color: #0369a1; text-decoration: none; font-size: 14px; padding: 3px 0; display: block;\" href=\"#s8\">8. Udv\u00e6lgelse af ZQ-serien til koreansk oftalmisk produktion<\/a><br \/>\n<a style=\"color: #0369a1; text-decoration: none; font-size: 14px; padding: 3px 0; display: block;\" href=\"#faq\">Ofte stillede sp\u00f8rgsm\u00e5l<\/a><\/div>\n<\/nav>\n<p><!-- S1 --><\/p>\n<section id=\"s1\" style=\"margin: 56px 0 0; padding: 36px 0 0; border-top: 2px solid #0369a1;\">\n<h2 style=\"font-size: clamp(18px,2.6vw,24px); font-weight: 800; color: #0369a1; margin: 0 0 18px;\">1. Korean Ophthalmic Market and IBM&#8217;s Role<\/h2>\n<figure style=\"margin: 0 0 22px;\"><img decoding=\"async\" style=\"width: 100%; height: auto; border-radius: 8px; display: block;\" title=\"Korean HDPE Ophthalmic Containers \u2014 IBM Production\" src=\"https:\/\/isbm-blow-molding.com\/wp-content\/uploads\/2026\/07\/Pharmaceutical-Bottles.webp\" alt=\"Korean HDPE ophthalmic eye drop bottles \u2014 10ml injection blow molded pharmaceutical container with dropper cap 13\/415 neck finish, 0.35mm body wall translucency for fill-level inspection, produced by Korea Ever-Power ZQ80 ZQ110 at 20-24 cavity Korean pharmaceutical ophthalmic IBM production for Korean KFDA ophthalmic container qualification\" \/><figcaption style=\"font-size: 12px; color: #6b7280; margin-top: 8px; text-align: center;\">Koreanske farmaceutiske 10 ml HDPE oftalmiske beholdere produceret ved spr\u00f8jtest\u00f8bning \u2014 med 13\/415 dr\u00e5bet\u00e6llerhalsfinish med \u00b10,05 mm ydre diametertolerance for indgreb med dr\u00e5bet\u00e6llerh\u00e6tte, en husv\u00e6g p\u00e5 0,30-0,40 mm, der muligg\u00f8r inspektion af gennemskinneligt fyldningsniveau, og en spr\u00f8jtest\u00f8bt bund uden s\u00f8m eller vidnesbyrd, der er synligt udefra. Med 20-30 hulrum pr. cyklus er IBM den eneste bl\u00e6sest\u00f8bningsproces, der producerer koreanske oftalmiske volumener i farmaceutisk kvalitet og \u00f8konomisk skala samtidigt.<\/figcaption><\/figure>\n<p style=\"font-size: 16px; margin-bottom: 14px;\">Korea&#8217;s ophthalmic pharmaceutical market is among the largest and fastest-growing in East Asia. Three structural factors drive Korean ophthalmic container demand above what Korea&#8217;s population size alone would suggest: the world&#8217;s highest rate of contact lens wear per capita (approximately 42% of Korean adults aged 20\u201340 wear contact lenses, generating daily artificial tear and contact lens solution demand), the exceptionally high Korean screen time (Korean workers average 9.4 hours per day of screen exposure, driving rapidly growing dry-eye disease prevalence), and Korea&#8217;s nationally covered ophthalmic prescription reimbursement system (Korean National Health Insurance covers most ophthalmic prescription medications, lowering the price barrier to ophthalmic pharmaceutical use). These three factors together produce an estimated 500+ million annual ophthalmic container demand in Korea, split between prescription ophthalmic (antibiotics, anti-inflammatory, antiglaucoma), OTC artificial tears, and contact lens care products \u2014 all requiring 10 ml HDPE IBM containers.<\/p>\n<p style=\"font-size: 16px; margin-bottom: 0;\">IBM er den koreanske standard for oftalmiske beholderprocesser, fordi det oftalmiske format p\u00e5 10 ml unikt drager fordel af alle IBMs tekniske fordele samtidig: spr\u00f8jtest\u00f8bt hals ved \u00b10,05 mm (indgreb med dr\u00e5beh\u00e6tte kr\u00e6ver \u00b10,06 mm), nul flash (KFDA oftalmisk partikeloverholdelse), output fra flere kaviteter p\u00e5 op til 30 kaviteter (produktions\u00f8konomi ved et \u00e5rligt behov p\u00e5 over 500 millioner enheder) og en gennemskinnelig HDPE-kavitetsv\u00e6g ved 0,30-0,40 mm (inspektion af fyldningsniveau uden krav til gennemsigtighed). Ingen anden bl\u00e6sest\u00f8bningsproces leverer alle fire fordele ved 10 ml-formatet. Den bredere kontekst af IBM for koreansk farmaceutisk produktion er d\u00e6kket i <a style=\"color: #0369a1; font-weight: 600; text-decoration: none;\" href=\"https:\/\/isbm-blow-molding.com\/da\/pharmaceutical-injection-blow-molding\/\">farmaceutisk IBM-guide<\/a>Denne artikel fokuserer specifikt p\u00e5 produktion af 10 ml HDPE oftalmiske beholdere.<\/p>\n<\/section>\n<p><!-- S2 --><\/p>\n<section id=\"s2\" style=\"margin: 56px 0 0; padding: 36px 0 0; border-top: 2px solid #e5e7eb;\">\n<h2 style=\"font-size: clamp(18px,2.6vw,24px); font-weight: 800; color: #0369a1; margin: 0 0 18px;\">2. Specifikationer for 10 ml HDPE oftalmisk beholder<\/h2>\n<figure style=\"margin: 0 0 22px;\"><img decoding=\"async\" style=\"width: 100%; height: auto; border-radius: 8px; display: block;\" title=\"10ml Ophthalmic IBM Process \u2014 Korea Ever-Power\" src=\"https:\/\/isbm-blow-molding.com\/wp-content\/uploads\/2026\/07\/IBM-operating-principle.webp\" alt=\"IBM 3-station process for 10ml ophthalmic HDPE container \u2014 Station 1 injection at 800-1350KN of 10ml preform with 13\/415 dropper neck insert, Station 2 blow moulding to 25mm body diameter 45mm height, Station 3 stripping \u2014 20-30 cavity simultaneous production on Korea Ever-Power ZQ80 ZQ110 ZQ135 for Korean ophthalmic pharmaceutical HDPE IBM production\" \/><figcaption style=\"font-size: 12px; color: #6b7280; margin-top: 8px; text-align: center;\">IBM 3-stationsproces anvendt til produktion af 10 ml oftalmiske beholdere \u2014 alle tre stationer udf\u00f8res samtidigt, hvor 20-30 oftalmiske pr\u00e6forme spr\u00f8jtest\u00f8bes p\u00e5 Station 1, mens 20-30 flasker fra den foreg\u00e5ende cyklus bl\u00e6ses p\u00e5 Station 2, og 20-30 f\u00e6rdige flasker fra den foreg\u00e5ende cyklus strippes p\u00e5 Station 3. Den samtidige udf\u00f8relse er grunden til, at IBM med 30 kaviteter opn\u00e5r cirka 23.800 oftalmiske flasker i timen, p\u00e5 trods af at hver station tager flere sekunder.<\/figcaption><\/figure>\n<p style=\"font-size: 16px; margin-bottom: 20px;\">Koreanske 10 ml HDPE oftalmiske beholdere f\u00f8lger en bem\u00e6rkelsesv\u00e6rdigt standardiseret dimensionsspecifikation p\u00e5 tv\u00e6rs af koreanske farmaceutiske m\u00e6rker \u2013 standardisering drevet af kompatibilitet med dr\u00e5beh\u00e6ttesystemer leveret af koreanske producenter af dr\u00e5beh\u00e6tter og af koreanske farmaceutiske p\u00e5fyldningslinjespecifikationer, der er optimeret til standarddimensioner p\u00e5 10 ml oftalmiske beholdere.<\/p>\n<div style=\"overflow-x: auto; margin: 0 0 22px;\">\n<table style=\"width: 100%; border-collapse: collapse; font-size: 13.5px; min-width: 460px;\">\n<thead>\n<tr style=\"background: #0369a1;\">\n<th style=\"color: #fff; padding: 10px 12px; text-align: left; font-weight: bold;\">Dimension<\/th>\n<th style=\"color: #fff; padding: 10px 12px; text-align: center; font-weight: bold;\">Specifikation<\/th>\n<th style=\"color: #fff; padding: 10px 12px; text-align: left; font-weight: bold;\">Funktion \/ Kravgrundlag<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; font-weight: 600;\">Halsfinish<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center; font-weight: bold;\">13\/415 GPI<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd;\">Standard koreansk oftalmisk dr\u00e5beh\u00e6ttegr\u00e6nseflade \u2014 kompatibel med koreanske dr\u00e5beh\u00e6tte- og CRC-leverand\u00f8rer af oftalmiske h\u00e6tter<\/td>\n<\/tr>\n<tr style=\"background: #f0f9ff;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; font-weight: 600;\">Tolerance for halsens yderdiameter<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center; font-weight: bold; color: #0369a1;\">13,00 mm \u00b10,05 mm<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd;\">Tolerancevindue for snap-fit-indgreb p\u00e5 pipetteh\u00e6tte \u2014 IBM native, \u00b10,05 mm p\u00e5 tv\u00e6rs af alle hulrum<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; font-weight: 600;\">Borings-ID<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center; font-weight: bold;\">9,0 mm \u00b10,04 mm<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd;\">Indgreb med ydre diameter p\u00e5 dropperindsats \u2014 defineret af kernestangens ydre diameter i IBM-spr\u00f8jtest\u00f8beformen<\/td>\n<\/tr>\n<tr style=\"background: #f0f9ff;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; font-weight: 600;\">Beholderh\u00f8jde<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center; font-weight: bold;\">42\u201352 mm<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd;\">Kompatibilitet med griber til koreansk p\u00e5fyldningslinje og dimensioner for koreansk apoteksdispenseringsbakke<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; font-weight: 600;\">Maksimal kropsdiameter<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center; font-weight: bold;\">22\u201328 mm<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd;\">R\u00e6kkeafstand mellem enkeltdosisbakker p\u00e5 apoteker \u2014 maks. 28 mm for standard koreansk bakkekompatibilitet<\/td>\n<\/tr>\n<tr style=\"background: #f0f9ff;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; font-weight: 600;\">Kropsv\u00e6gtykkelse<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center; font-weight: bold; color: #0369a1;\">0,30\u20130,40 mm<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd;\">Gennemsigtighed til inspektion af fyldningsniveau; \u22640,40 mm for tilstr\u00e6kkelig HDPE-gennemsigtighed ved 10 ml volumen<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; font-weight: 600;\">Volumenn\u00f8jagtighed<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center; font-weight: bold;\">10,0 ml \u00b10,5 ml<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd;\">Koreansk KFDA oftalmisk fyldningsvolumenstolerance \u2014 fyldningsm\u00e6rkets position p\u00e5 IBM-beholderen skal afspejle denne tolerance ved 23\u00b0C<\/td>\n<\/tr>\n<tr style=\"background: #f0f9ff;\">\n<td style=\"padding: 9px 12px; font-weight: 600;\">Flaskev\u00e6gt<\/td>\n<td style=\"padding: 9px 12px; text-align: center; font-weight: bold;\">2,5\u20134,5 g<\/td>\n<td style=\"padding: 9px 12px;\">HDPE IBM med en karosseriv\u00e6g p\u00e5 0,30-0,40 mm \u2014 lettere end EBM-\u00e6kvivalent; v\u00e6gt fra hulrum til hulrum CV% \u22644% specifikation<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p style=\"font-size: 16px; margin-bottom: 0;\">The 13\/415 neck finish specification is critical for Korean ophthalmic IBM mould design: the 13 mm nominal neck OD and 415 thread count (15 threads per inch) are the international standard for ophthalmic dropper closures adopted by Korean ophthalmic pharmaceutical brands and Korean dropper cap manufacturers. IBM container moulds for Korean ophthalmic production must specify 13\/415 neck inserts in the injection mould to the same dimensional accuracy as the Korean dropper cap tooling \u2014 \u00b10.02 mm on the neck OD at the injection mould neck cavity insert ensures that the finished IBM bottle&#8217;s \u00b10.05 mm neck OD tolerance is achieved with process margin on both sides of the dropper cap engagement window.<\/p>\n<\/section>\n<p><!-- S3 --><\/p>\n<section id=\"s3\" style=\"margin: 56px 0 0; padding: 36px 0 0; border-top: 2px solid #e5e7eb;\">\n<h2 style=\"font-size: clamp(18px,2.6vw,24px); font-weight: 800; color: #0369a1; margin: 0 0 18px;\">3. IBM Neck Precision til indgreb med dropperh\u00e6tte<\/h2>\n<figure style=\"margin: 0 0 22px;\"><img decoding=\"async\" style=\"width: 100%; height: auto; border-radius: 8px; display: block;\" title=\"IBM Ophthalmic Neck Mould Precision \u2014 Korea Ever-Power\" src=\"https:\/\/isbm-blow-molding.com\/wp-content\/uploads\/2026\/07\/IBM-mold-2.webp\" alt=\"IBM injection blow molding mould precision \u2014 13\/415 ophthalmic neck insert in injection mould core rod assembly showing \u00b10.02mm neck OD cavity tolerance producing \u00b10.05mm IBM bottle neck OD across all 20-30 production cavities \u2014 Korea Ever-Power pharmaceutical ophthalmic mould S136 stainless steel neck insert for Korean KFDA ophthalmic dropper cap engagement qualification\" \/><figcaption style=\"font-size: 12px; color: #6b7280; margin-top: 8px; text-align: center;\">IBM ophthalmic neck precision \u2014 the injection mould&#8217;s 13\/415 neck insert (S136 stainless, HRC 50\u201352) defines the ophthalmic container neck at \u00b10.02 mm cavity dimensional tolerance, producing \u00b10.05 mm neck OD on finished IBM bottles across all 20\u201330 production cavities. The core rod holds the 9.0 mm bore ID throughout both injection and blow phases, ensuring the dropper insert engagement diameter is identical to the injection mould&#8217;s core rod OD regardless of blow air pressure variation between cycles.<\/figcaption><\/figure>\n<p style=\"font-size: 16px; margin-bottom: 14px;\">The Korean ophthalmic dropper cap system has two precision interface points with the IBM container neck: the outer snap-fit or thread engagement between the dropper cap skirt and the neck OD, and the inner bore engagement between the dropper insert&#8217;s controlled orifice body and the neck bore ID. Both interfaces require dimensional precision that IBM provides natively through its injection mould tooling and core rod mechanism.<\/p>\n<h3 style=\"font-size: clamp(16px,2vw,20px); color: #0369a1; font-weight: bold; margin: 0 0 10px;\">Ydre klikforbindelse: Halsdiameter \u00b10,05 mm<\/h3>\n<p style=\"font-size: 16px; margin-bottom: 14px;\">Korean ophthalmic dropper caps engage the IBM bottle neck at the 13 mm OD by a circumferential bead on the cap skirt that snaps over the neck&#8217;s retaining flange. This snap-fit engagement provides: tamper evidence (the bead breaks an induction seal or deforms the retaining flange on first opening), child resistance (some Korean ophthalmic CRC formats require push-and-turn action), and closure retention during Korean pharmacy dispensing handling (the cap must remain attached to the bottle when tapped on a Korean pharmacy dispensing tray). The snap-fit mechanism&#8217;s function depends on the interference between the cap bead inner diameter and the bottle neck flange OD \u2014 the designed interference is typically 0.08\u20130.15 mm (the cap bead is 0.08\u20130.15 mm smaller in diameter than the neck flange OD). With IBM&#8217;s \u00b10.05 mm neck OD tolerance, the interference varies between 0.08\u20130.15 mm \u00b10.05 mm across all cavities \u2014 always within the range where snap-fit engagement occurs without cap opening force being excessive for Korean pharmacists or patients. With EBM&#8217;s \u00b10.15\u20130.25 mm neck OD tolerance, the interference variation of \u00b10.15\u20130.25 mm would produce, at the low end, engagement that is either absent (cap falls off) or, at the high end, engagement that requires destructive force to open \u2014 neither acceptable in Korean ophthalmic pharmaceutical distribution.<\/p>\n<h3 style=\"font-size: clamp(16px,2vw,20px); color: #0369a1; font-weight: bold; margin: 28px 0 10px;\">Indvendig boringsgr\u00e6nseflade: Dropperindsats\u00e5bning ved \u00b10,04 mm<\/h3>\n<p style=\"font-size: 16px; margin-bottom: 0;\">The dropper insert \u2014 the controlled-orifice component that produces a consistent 25\u201335 microlitre drop volume per squeeze \u2014 seats inside the IBM bottle neck bore, with its outer body in contact with the bore inner surface. The drop volume delivered by the dropper insert depends on two factors: the orifice diameter (controlled by the dropper insert mould tooling) and the bore-insert interference fit (controlled by the IBM bore ID versus the dropper insert OD). If the IBM bore is too small (below nominal), the dropper insert compresses inward and distorts the orifice geometry \u2014 producing smaller drop volumes than specified. If the IBM bore is too large (above nominal), the dropper insert can tilt within the bore, creating asymmetric orifice orientation that produces erratic drop trajectory in Korean patient use. IBM&#8217;s core rod defines the bore ID at \u00b10.04 mm across all cavities through the direct mechanical relationship between the core rod OD and the bore it forms during injection \u2014 the bore is not blown, not stretched, not dependent on air pressure, and does not vary with process parameter fluctuation at the blow station.<\/p>\n<\/section>\n<p><!-- S4 --><\/p>\n<section id=\"s4\" style=\"margin: 56px 0 0; padding: 36px 0 0; border-top: 2px solid #e5e7eb;\">\n<h2 style=\"font-size: clamp(18px,2.6vw,24px); font-weight: 800; color: #0369a1; margin: 0 0 18px;\">4. HDPE-kvalitet og forarbejdning til oftalmologisk IBM<\/h2>\n<p style=\"font-size: 16px; margin-bottom: 14px;\">Koreansk oftalmisk HDPE IBM bruger en sn\u00e6vrere harpiksspecifikation end generel farmaceutisk IBM \u2014 kombinationen af \u200b\u200btynd v\u00e6g (0,30-0,40 mm), et h\u00f8jt antal kaviteter (20-30 kaviteter), lange varmekanalbaner og koreanske KFDA-krav til ekstraherbare materialer skaber et specifikationss\u00e6t, der indsn\u00e6vrer det anvendelige HDPE-kvalitetsomr\u00e5de til MI 0,3-0,5 ved 190 \u00b0C\/2,16 kg og en densitet 0,950-0,960 g\/cm\u00b3 for st\u00f8rstedelen af \u200b\u200bkoreanske oftalmiske IBM-applikationer.<\/p>\n<div style=\"display: flex; flex-wrap: wrap; gap: 14px; margin: 16px 0 24px;\">\n<div style=\"flex: 1 1 260px; background: #f0f9ff; border-left: 4px solid #0369a1; border-radius: 0 6px 6px 0; padding: 16px 20px;\">\n<p style=\"font-weight: bold; color: #0369a1; margin: 0 0 8px;\">Specifikation af harpikskvalitet<\/p>\n<ul style=\"margin: 0; padding-left: 18px; display: flex; flex-direction: column; gap: 5px; font-size: 14px; color: #374151; line-height: 1.65;\">\n<li>MI: 0,3\u20130,5 g\/10 min (190 \u00b0C \/ 2,16 kg)<\/li>\n<li>Densitet: 0,950\u20130,960 g\/cm\u00b3<\/li>\n<li>Tils\u00e6tningsstoffer: Kun KFDA-positivliste<\/li>\n<li>Ingen UV-stabilisatorer, ingen slipmidler<\/li>\n<li>Antioxidant: AO-1010 eller AO-168 \u22640,05%<\/li>\n<li>KFDA-erkl\u00e6ring om farmaceutisk kontakt p\u00e5kr\u00e6vet<\/li>\n<\/ul>\n<\/div>\n<div style=\"flex: 1 1 260px; background: #f0f9ff; border-left: 4px solid #0284c7; border-radius: 0 6px 6px 0; padding: 16px 20px;\">\n<p style=\"font-weight: bold; color: #0369a1; margin: 0 0 8px;\">Behandlingsparametre (ZQ80\/ZQ110)<\/p>\n<ul style=\"margin: 0; padding-left: 18px; display: flex; flex-direction: column; gap: 5px; font-size: 14px; color: #374151; line-height: 1.65;\">\n<li>T\u00f8nde: 175\u2192195\u2192210\u2192215\u2192215\u00b0C<\/li>\n<li>Injektionstryk: 90\u2013130 MPa<\/li>\n<li>Fyldningstid: 0,6\u20131,0 s (tyndv\u00e6gget)<\/li>\n<li>Hold: 50\u201365% peak, 0,4\u20130,8 s<\/li>\n<li>Bl\u00e6seluft: 0,5\u20130,8 MPa<\/li>\n<li>Bl\u00e6sehold: 0,7\u20131,2 s<\/li>\n<li>Formtemperatur: 12\u201322\u00b0C<\/li>\n<\/ul>\n<\/div>\n<div style=\"flex: 1 1 260px; background: #f0f9ff; border-left: 4px solid #0ea5e9; border-radius: 0 6px 6px 0; padding: 16px 20px;\">\n<p style=\"font-weight: bold; color: #0369a1; margin: 0 0 8px;\">Kritiske kvalitetskontroller<\/p>\n<ul style=\"margin: 0; padding-left: 18px; display: flex; flex-direction: column; gap: 5px; font-size: 14px; color: #374151; line-height: 1.65;\">\n<li>Hals-YD: 13,00 \u00b10,05 mm \u2014 alle hulrum<\/li>\n<li>Borings-ID: 9,0 \u00b10,04 mm \u2014 alle hulrum<\/li>\n<li>Flaskev\u00e6gt: \u00b14% CV% p\u00e5 tv\u00e6rs af hulrummene<\/li>\n<li>V\u00e6ggennemsigtighed: Best\u00e5 visuel kontrol af fyldningsniveau<\/li>\n<li>Tilslutning af pipetteh\u00e6tte: 100% klikl\u00e5s online<\/li>\n<li>Partikelformet: best\u00e5 KFDA oftalmisk standard<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<p style=\"font-size: 16px; margin-bottom: 0;\"><strong>V\u00e6ggennemsigtighed og interaktion mellem HDPE-kvalitet:<\/strong> Korean ophthalmic containers must allow Korean pharmacists and Korean patients to visually inspect the liquid fill level \u2014 a requirement that limits HDPE wall thickness to \u22640.40 mm at the body panel, where HDPE&#8217;s semi-crystalline structure transmits sufficient light at this thickness for fill-level judgement. At 0.50 mm body wall, standard HDPE at density 0.955 g\/cm\u00b3 becomes opaque enough that fill-level inspection is unreliable. The 0.30\u20130.40 mm body wall is a design constraint that the IBM mould designer must achieve through the preform geometry and blow ratio \u2014 and that the IBM operator must verify in production through periodic wall thickness measurement at the minimum body wall location using ultrasonic gauge measurement.<\/p>\n<\/section>\n<p><!-- S5 --><\/p>\n<section id=\"s5\" style=\"margin: 56px 0 0; padding: 36px 0 0; border-top: 2px solid #e5e7eb;\">\n<h2 style=\"font-size: clamp(18px,2.6vw,24px); font-weight: 800; color: #0369a1; margin: 0 0 18px;\">5. Koreanske KFDA-kvalifikationskrav til oftalmiske beholdere<\/h2>\n<p style=\"font-size: 16px; margin-bottom: 14px;\">De koreanske KFDA-kvalificeringskrav til oftalmiske farmaceutiske beholdere er strengere end de generelle krav til farmaceutiske beholdere p\u00e5 to specifikke omr\u00e5der: standarder for partikelforurening og varigheden af \u200b\u200bkompatibilitetstest. Disse strengere krav afspejler den oftalmiske administrationsvej \u2014 \u00f8jets overflade er meget f\u00f8lsom over for partikel- og kemiske p\u00e5virkninger, og de koreanske KFDA-sikkerhedsstandarder for oftalmiske produkter er kalibreret i overensstemmelse hermed.<\/p>\n<h3 style=\"font-size: clamp(16px,2vw,20px); color: #0369a1; font-weight: bold; margin: 0 0 10px;\">Oftalmiske partikelstandarder (KFDA \/ Koreansk farmakop\u00e9)<\/h3>\n<p style=\"font-size: 16px; margin-bottom: 14px;\">Korean Pharmacopoeia (KP) aligns with USP &lt;790&gt; for visible particulates in ophthalmic preparations and USP &lt;788&gt; for sub-visible particulate matter in ophthalmic preparations. For Korean IBM ophthalmic container qualification, particulate testing applies in two stages: container wash-extract testing (empty containers filled with purified water, agitated and examined for visible particulate and sub-visible particulate count) and filled product testing (Korean ophthalmic formulation filled into IBM containers examined at end of proposed shelf life). IBM container wash-extract particulate limits per KP ophthalmic container test: visible particles \u2014 absent (zero visible particles in wash extract when examined under Korean Pharmacopoeia visible inspection method); sub-visible particles per KP (aligned with USP &lt;788&gt;): \u226425 particles\/ml \u226510 \u03bcm, \u22643 particles\/ml \u226525 \u03bcm. IBM&#8217;s zero-flash production eliminates the most significant source of sub-visible particulate in blow-moulded pharmaceutical containers \u2014 the plastic fines generated by EBM flash trimming. Korea Ever-Power&#8217;s pharmaceutical IBM documentation package includes a reference statement on IBM&#8217;s zero-flash architecture for use in the Korean pharmaceutical container qualification documentation that addresses Korean KFDA questions on particle contamination prevention during container production.<\/p>\n<h3 style=\"font-size: clamp(16px,2vw,20px); color: #0369a1; font-weight: bold; margin: 28px 0 10px;\">Kompatibilitetstestvarighed for oftalmiske IBM-containere<\/h3>\n<p style=\"font-size: 16px; margin-bottom: 0;\">Korean KFDA ophthalmic pharmaceutical container compatibility testing requires a 24-month accelerated stability study at 40\u00b0C\/75% RH \u2014 12 months longer than the 12-month standard for most oral pharmaceutical container compatibility studies. The longer study period reflects the Korean KFDA position that ophthalmic formulations&#8217; complex mixture of active ingredients, preservatives (benzalkonium chloride, thimerosal, or preservative-free buffer systems) and buffering agents creates a more complex extractable interaction profile with HDPE than simple aqueous solutions. Korean IBM ophthalmic packaging producers should plan for 24-month compatibility studies \u2014 which means beginning the filled container compatibility study immediately upon first IBM production at qualification conditions, so that the 24-month study result is available within the overall Korean ophthalmic product development timeline without delaying the KFDA submission.<\/p>\n<\/section>\n<p><!-- S6 --><\/p>\n<section id=\"s6\" style=\"margin: 56px 0 0; padding: 36px 0 0; border-top: 2px solid #e5e7eb;\">\n<h2 style=\"font-size: clamp(18px,2.6vw,24px); font-weight: 800; color: #0369a1; margin: 0 0 18px;\">6. IBM Cleanroom-ops\u00e6tning til koreansk oftalmisk produktion<\/h2>\n<figure style=\"margin: 0 0 22px;\"><img decoding=\"async\" style=\"width: 100%; height: auto; border-radius: 8px; display: block;\" title=\"IBM Ophthalmic Cleanroom Production Line \u2014 Korea Ever-Power\" src=\"https:\/\/isbm-blow-molding.com\/wp-content\/uploads\/2026\/07\/IBM-PRODUCTION-LINE-COMPONENTS.webp\" alt=\"Korea Ever-Power IBM ophthalmic pharmaceutical production line \u2014 ZQ series machine with HEPA positive-pressure cleanroom enclosure over mould area dual chiller mould temperature controllers oil-free air compressor output conveyor for Korean KFDA ophthalmic container production in ISO Class 8 cleanroom environment\" \/><figcaption style=\"font-size: 12px; color: #6b7280; margin-top: 8px; text-align: center;\">Komponenter til den koreanske Ever-Power IBM oftalmiske produktionslinje \u2014 den komplette produktionscelle til koreansk KFDA-produktion af oftalmiske beholdere \u2014 omfatter ZQ-seriens maskine med HEPA-indkapsling over st\u00f8bestationen og udgangstransport\u00f8ren, oliefri kompressor (obligatorisk for oftalmisk luftforsyning), dobbeltk\u00f8ler til uafh\u00e6ngige injektions- og bl\u00e6sest\u00f8betemperaturkredsl\u00f8b og HEPA-filtreret udgangstransport\u00f8r for at opretholde renlighed helt frem til palleteringsstationen.<\/figcaption><\/figure>\n<p style=\"font-size: 16px; margin-bottom: 14px;\">Koreansk produktion af oftalmiske IBM-beholdere udf\u00f8res typisk i renrumsmilj\u00f8er i ISO-klasse 8 (svarende til koreansk GMP-kvalitet D). De specifikke renrumskrav til produktion af oftalmiske IBM-beholdere \u2013 som adskiller sig fra den generelle farmaceutiske IBM-renrumsops\u00e6tning, der er beskrevet i den farmaceutiske IBM-vejledning \u2013 afspejler den h\u00f8jere partikelf\u00f8lsomhed i koreanske oftalmiske beholdere.<\/p>\n<ul style=\"margin: 0 0 24px; padding-left: 20px; display: flex; flex-direction: column; gap: 12px;\">\n<li style=\"font-size: 16px; color: #374151; line-height: 1.7;\"><strong style=\"color: #0369a1;\">HEPA-tilf\u00f8rselsluft over st\u00f8beformstation:<\/strong> The IBM machine&#8217;s mould area \u2014 where containers are formed and where the core rods deposit finished containers onto the output conveyor \u2014 should receive HEPA-filtered supply air at \u22650.45 m\/s face velocity downward into the open mould area. This positive-pressure HEPA supply air prevents airborne particles from entering the open container mouth during the time between stripping (Station 3) and cap application at the downstream Korean pharmaceutical filling line. The HEPA enclosure over the mould station is specified as a separate engineering item in the Korean ophthalmic IBM cell design \u2014 Korea Ever-Power provides connection points and dimensional data for the HEPA enclosure installation on the ZQ machine outline drawings.<\/li>\n<li style=\"font-size: 16px; color: #374151; line-height: 1.7;\"><strong style=\"color: #0369a1;\">Oliefri trykluft \u2014 obligatorisk:<\/strong> Trykluft, der anvendes til IBM-bl\u00e6sest\u00f8bning af koreanske oftalmiske beholdere, skal v\u00e6re oliefri p\u00e5 brugsstedet \u2014 ISO 8573-1 Klasse 0 for olieaerosol og oliedamp. Oliekontaminering af IBM-bl\u00e6seluften ved bl\u00e6sestationen kommer i kontakt med HDPE-pr\u00e6formens indre under oppustning og bliver et ekstraherbart forurenende stof i den f\u00e6rdige beholder. Koreanske producenter af oftalmiske IBM skal specificere oliefri skruekompressorer (ikke oliesmurte stempelkompressorer med downstream-filtre) og skal verificere oliefri status ved maskinens tilslutningspunkt med regelm\u00e6ssig overv\u00e5gning af partikler og oliedamp i henhold til koreanske protokoller for overv\u00e5gning af trykluftkvaliteten inden for farmaceutiske produkter.<\/li>\n<li style=\"font-size: 16px; color: #374151; line-height: 1.7;\"><strong style=\"color: #0369a1;\">HEPA-indkapsling af udgangstransport\u00f8r:<\/strong> Koreanske oftalmiske beholdere, der forlader IBM-maskinen ved Station 3, k\u00f8rer p\u00e5 et udgangstransportb\u00e5nd, f\u00f8r de samles i poser eller bakker til transport til den koreanske farmaceutiske p\u00e5fyldningslinje. Denne transportb\u00e5ndssektion b\u00f8r ogs\u00e5 v\u00e6re HEPA-indkapslet for at opretholde beholderens renlighed fra IBM-maskinens udgang til indsamlingsstedet. Transportb\u00e5ndets HEPA-indkapsling er typisk installeret som en tunnel med HEPA-tilf\u00f8rselsluft med positivt tryk og en filtreret udst\u00f8dning ved transportb\u00e5ndets udgang. Uden et transportb\u00e5ndsindkapsling kan koreanske oftalmiske IBM-beholdere akkumulere luftb\u00e5rne partikler under transportb\u00e5ndets transport, som derefter s\u00e6tter sig i den \u00e5bne beholder\u00e5bning og bidrager til et mindre synligt partikelantal i den fyldte beholder.<\/li>\n<\/ul>\n<\/section>\n<p><!-- S7 --><\/p>\n<section id=\"s7\" style=\"margin: 56px 0 0; padding: 36px 0 0; border-top: 2px solid #e5e7eb;\">\n<h2 style=\"font-size: clamp(18px,2.6vw,24px); font-weight: 800; color: #0369a1; margin: 0 0 18px;\">7. \u00d8konomi for kavitetsm\u00e5ling for koreansk oftalmisk IBM<\/h2>\n<p style=\"font-size: 16px; margin-bottom: 14px;\">Cavity count selection for Korean ophthalmic IBM is the highest-impact single investment decision \u2014 because the Korean ophthalmic container market&#8217;s 500M+ annual unit demand requires matching machine cavity count to annual production volume with enough precision that the machine runs at 70\u201390% utilisation (below 60% utilisation wastes capital; above 90% utilisation creates production risk from unscheduled maintenance). The following analysis compares three ZQ models for a Korean ophthalmic contract packaging factory with a specific annual volume requirement.<\/p>\n<div style=\"overflow-x: auto; margin: 16px 0 24px;\">\n<table style=\"width: 100%; border-collapse: collapse; font-size: 13.5px; min-width: 500px;\">\n<thead>\n<tr style=\"background: #0369a1;\">\n<th style=\"color: #fff; padding: 10px 12px; text-align: left; font-weight: bold;\">Parameter<\/th>\n<th style=\"color: #fff; padding: 10px 12px; text-align: center; font-weight: bold;\">ZQ80 (20 kav.)<\/th>\n<th style=\"color: #fff; padding: 10px 12px; text-align: center; font-weight: bold;\">ZQ110 (24 kav.)<\/th>\n<th style=\"color: #fff; padding: 10px 12px; text-align: center; font-weight: bold;\">ZQ135 (30 kav.)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; font-weight: 600;\">Flasker\/time (88% eff.)<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center;\">~15,840<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center; font-weight: bold; color: #0369a1;\">~19,000<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center; font-weight: bold; color: #0369a1;\">~23,760<\/td>\n<\/tr>\n<tr style=\"background: #f0f9ff;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; font-weight: 600;\">Flasker\/Koreansk 2-holds vagt (14 timer)<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center;\">~221,760<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center;\">~266,000<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center;\">~332,640<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; font-weight: 600;\">Flasker\/\u00e5r (250 dage)<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center;\">~55,4 mio.<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center; font-weight: bold; color: #0369a1;\">~66,5 mio.<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center; font-weight: bold; color: #0369a1;\">~83,2 mio.<\/td>\n<\/tr>\n<tr style=\"background: #f0f9ff;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; font-weight: 600;\">Maskiner til 200 millioner enheder\/\u00e5r<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center;\">4 maskiner<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center;\">3 maskiner<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center; font-weight: bold; color: #0369a1;\">3 maskiner (72% betjeningsenhed)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 9px 12px; font-weight: 600;\">KFDA-kvalifikationer kr\u00e6ves<\/td>\n<td style=\"padding: 9px 12px; text-align: center; color: #dc2626;\">4 maskinkvaliteter<\/td>\n<td style=\"padding: 9px 12px; text-align: center; color: #f59e0b;\">3 maskinkvaliteter<\/td>\n<td style=\"padding: 9px 12px; text-align: center; color: #166534; font-weight: bold;\">3 maskinkvaliteter (laveste pr. enhed)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p style=\"font-size: 16px; margin-bottom: 0;\">Tabellen over kavitetsantal viser, at for en koreansk oftalmisk kontraktpakker, der sigter mod 200 millioner \u00e5rlige 10 ml enheder, kr\u00e6ver ZQ135 ved 30 kaviteter det samme antal maskiner som ZQ110 ved 24 kaviteter (3 maskiner i begge tilf\u00e6lde), men k\u00f8rer med en udnyttelsesgrad p\u00e5 72% versus 100% \u2013 hvilket giver produktionskapacitet til uplanlagt vedligeholdelse, nedetid ved format\u00e6ndringer og \u00e5rlig eftersp\u00f8rgselsv\u00e6kst uden at kr\u00e6ve et fjerde maskink\u00f8b. Antallet af koreanske KFDA-maskinkvalifikationer minimeres ogs\u00e5 ved det h\u00f8jere kavitetsantal (3 kvalifikationer ved ZQ135 versus 4 ved ZQ80) \u2013 hver maskinkvalifikation repr\u00e6senterer 16-24 ugers testtidslinje og betydelige dokumentationsomkostninger. For koreanske oftalmiske kontraktpakkerfaciliteter, der s\u00f8ger at minimere deres samlede antal KFDA-maskinkvalifikationer, samtidig med at produktionsredundansen opretholdes, er ZQ135 eller ZQ110 klart den rigtige investering i forhold til flere ZQ80-maskiner med tilsvarende \u00e5rlig produktion. Korea Ever-Power <a style=\"color: #0369a1; font-weight: 600; text-decoration: none;\" href=\"https:\/\/isbm-blow-molding.com\/da\/product\/ep-zq110-injection-blow-molding-machine-european-style\/\">EP-ZQ110<\/a> er den mest almindelige startplatform for koreanske oftalmiske kontraktpakkere, hvis \u00e5rlige volumen ligger i intervallet 50 millioner-80 millioner enheder pr. maskine.<\/p>\n<\/section>\n<p><!-- S8 --><\/p>\n<section id=\"s8\" style=\"margin: 56px 0 0; padding: 36px 0 0; border-top: 2px solid #e5e7eb;\">\n<h2 style=\"font-size: clamp(18px,2.6vw,24px); font-weight: 800; color: #0369a1; margin: 0 0 18px;\">8. Udv\u00e6lgelse af ZQ-serien til koreansk oftalmisk IBM-produktion<\/h2>\n<p style=\"font-size: 16px; margin-bottom: 14px;\">For koreansk oftalmisk IBM-produktion involverer valget mellem ZQ-seriens modeller ikke kun produktionshastighed og kapitalomkostninger, men ogs\u00e5 en farmaceutisk specifik overvejelse: den koreanske KFDA-kvalifikation er knyttet til den specifikke maskinmodel og antallet af kaviteter. F\u00f8lgende vejledning tager h\u00f8jde for denne farmaceutisk specifikke begr\u00e6nsning.<\/p>\n<div style=\"display: flex; flex-direction: column; gap: 12px; margin: 16px 0 24px;\">\n<div style=\"background: #f0f9ff; border-radius: 8px; padding: 18px 22px; border-left: 4px solid #0369a1;\">\n<p style=\"font-weight: bold; color: #0369a1; margin: 0 0 8px;\">Koreansk oftalmologisk startup \/ pr\u00f8veproduktion \u2192 ZQ60 (14 hulrum)<\/p>\n<p style=\"font-size: 15px; color: #374151; margin: 0; line-height: 1.65;\">\u00c5rligt volumen under 25 millioner enheder. Koreanske farmaceutiske startup-virksomheder, pilotprojekter med koreanske oftalmiske produktlinjer, koreansk CMO-testproduktion for internationale oftalmiske m\u00e6rker, der kommer ind i Korea. ZQ60-investeringen er passende til volumener under 25 millioner enheder, men kr\u00e6ver omhyggelig fremtidig planl\u00e6gning: opgradering fra ZQ60 til ZQ80 for et eksisterende KFDA-registreret koreansk oftalmisk produkt kr\u00e6ver en ny koreansk KFDA-maskine\u00e6ndringsmeddelelse og kvalificering af den nye maskine - en proces p\u00e5 3-6 m\u00e5neder. Koreanske producenter af oftalmiske emballager, der forventer at vokse til 30+ millioner enheder inden for 3 \u00e5r, b\u00f8r tage ZQ80 i brug fra starten og acceptere den indledende lavere udnyttelsesgrad og dermed undg\u00e5 kvalificeringsovergangsomkostningerne.<\/p>\n<\/div>\n<div style=\"background: #f0f9ff; border-radius: 8px; padding: 18px 22px; border-left: 4px solid #0284c7;\">\n<p style=\"font-weight: bold; color: #0369a1; margin: 0 0 8px;\">Koreansk mellemstor oftalmologi \u2192 ZQ80 (20 hulrum, 30-55 millioner enheder\/\u00e5r)<\/p>\n<p style=\"font-size: 15px; color: #374151; margin: 0; line-height: 1.65;\">The ZQ80&#8217;s dual hydraulic system (20\u201330% energy saving) and high-precision angle divider (standard at ZQ80+) make it the entry point for Korean ophthalmic production where energy efficiency and inter-cavity consistency are KFDA qualification requirements. At 20-cavity 10 ml production, ZQ80 produces approximately 55M ophthalmic bottles per Korean two-shift year \u2014 sufficient for Korean mid-scale pharmaceutical manufacturers serving Korean domestic ophthalmic market without export requirements.<\/p>\n<\/div>\n<div style=\"background: #f0f9ff; border-radius: 8px; padding: 18px 22px; border-left: 4px solid #0ea5e9;\">\n<p style=\"font-weight: bold; color: #0369a1; margin: 0 0 8px;\">Koreansk storskala oftalmologi \u2192 ZQ110 \/ ZQ135 (55 millioner\u201383 millioner+ enheder\/\u00e5r pr. maskine)<\/p>\n<p style=\"font-size: 15px; color: #374151; margin: 0; line-height: 1.65;\">Koreanske farmaceutiske kontraktpakkere, der betjener multinationale oftalmiske m\u00e6rker, koreanske farmaceutiske eksport\u00f8rer og koreanske nationale oftalmiske producenter, der betjener koreanske hospitalsforsyningsk\u00e6der p\u00e5 nationalt plan \u2014 kr\u00e6ver alle ZQ110- eller ZQ135-produktion for at opn\u00e5 de outputvolumener og KFDA-kvalificeringseffektivitet, som deres forretningsmodel kr\u00e6ver. <a style=\"color: #0369a1; font-weight: 600; text-decoration: none;\" href=\"https:\/\/isbm-blow-molding.com\/da\/product-category\/injection-blow-molding-machine\/\">fuldt udvalg af spr\u00f8jtest\u00f8bemaskiner<\/a> d\u00e6kker alle koreanske oftalmiske produktionsskalaer fra opstart til national farmaceutisk levering.<\/p>\n<\/div>\n<\/div>\n<\/section>\n<p><!-- FAQ --><\/p>\n<section style=\"margin: 56px 0 0; padding: 36px 0 0; border-top: 2px solid #0369a1;\">\n<h2 id=\"faq\" style=\"font-size: clamp(19px,2.8vw,25px); font-weight: 800; color: #0369a1; margin: 0 0 24px;\">Ofte stillede sp\u00f8rgsm\u00e5l<\/h2>\n<div style=\"display: flex; flex-direction: column; gap: 2px;\">\n<div style=\"border: 1px solid #bae6fd; border-radius: 8px 8px 0 0; overflow: hidden;\">\n<div style=\"background: #f0f9ff; padding: 14px 20px; border-bottom: 1px solid #bae6fd;\">\n<p style=\"font-size: 15px; font-weight: bold; color: #0369a1; margin: 0;\">Q1 \u2014 Hvad adskiller 10 ml oftalmiske IBM-beholdere teknisk set fra andre farmaceutiske IBM-beholdere?<\/p>\n<\/div>\n<div style=\"padding: 16px 20px;\">\n<p style=\"font-size: 15px; color: #374151; margin: 0; line-height: 1.7;\">10 ml ophthalmic IBM containers have four specific technical requirements that distinguish them from other pharmaceutical IBM containers. First, dual precision neck interface: ophthalmic containers require precision at both the outer neck OD (dropper cap snap-fit engagement at \u00b10.05 mm) and the inner neck bore (dropper insert orifice body at \u00b10.04 mm) simultaneously \u2014 most other pharmaceutical IBM containers require only outer neck OD precision for closure engagement. Second, body wall translucency: ophthalmic containers must allow visual fill-level inspection at 0.30\u20130.40 mm body wall \u2014 the thinnest wall specification in pharmaceutical IBM and one that requires specific preform design and blow ratio optimisation. Third, stricter particulate standards: Korean KFDA ophthalmic sub-visible particulate limits (\u226425 particles\/ml \u226510 \u03bcm) are more stringent than general pharmaceutical container particulate limits, requiring HEPA-enclosed production and oil-free compressed air at the IBM machine. Fourth, 24-month compatibility study: Korean KFDA ophthalmic container compatibility testing requires 24-month accelerated stability at 40\u00b0C\/75% RH versus 12 months for most oral pharmaceutical containers \u2014 doubling the qualification timeline for the compatibility component. Together, these four characteristics make 10 ml ophthalmic IBM the most technically demanding standard pharmaceutical IBM format, and the format where Korea Ever-Power&#8217;s pharmaceutical IBM expertise provides the most value in guiding mould design, machine specification and qualification documentation preparation.<\/p>\n<\/div>\n<\/div>\n<div style=\"border: 1px solid #bae6fd; border-top: none; overflow: hidden;\">\n<div style=\"background: #f0f9ff; padding: 14px 20px; border-bottom: 1px solid #bae6fd;\">\n<p style=\"font-size: 15px; font-weight: bold; color: #0369a1; margin: 0;\">Q2 \u2014 Kan den samme IBM-maskine og st\u00f8beform producere b\u00e5de 10 ml og 15 ml oftalmiske beholdere?<\/p>\n<\/div>\n<div style=\"padding: 16px 20px;\">\n<p style=\"font-size: 15px; color: #374151; margin: 0; line-height: 1.7;\">Yes, but with important constraints. IBM moulds are specific to a container geometry \u2014 the injection mould, blow mould, and stripping tool are all designed and manufactured for a specific container shape, volume and neck finish. Running both 10 ml and 15 ml ophthalmic containers on the same IBM machine requires two separate mould sets (one per container format) with a mould change procedure between formats. The IBM machine is format-flexible by design: Korea Ever-Power&#8217;s ZQ series machines accommodate any mould set within the machine&#8217;s platen dimensions and shot weight range, so a ZQ80 qualified for 10 ml ophthalmic can also run a 15 ml ophthalmic mould set after a mould change. However, each container format requires its own Korean KFDA pharmaceutical container qualification \u2014 the 10 ml qualification does not extend to 15 ml because the container drawing, neck dimensions, volume and wall thickness all differ between formats. Korean pharmaceutical IBM producers who produce multiple ophthalmic formats on the same machine must maintain separate KFDA qualification documentation for each format, including separate cavit-by-cavity dimensional reports and separate compatibility test reports. Mould change time between ophthalmic IBM formats on the ZQ series is typically 3\u20135 hours for trained operators \u2014 the heaviest component of ophthalmic mould change is the 20\u201330 cavity injection mould assembly, which requires a floor-mounted crane rated for 80\u2013150 kg (depending on cavity count) at the customer&#8217;s facility.<\/p>\n<\/div>\n<\/div>\n<div style=\"border: 1px solid #bae6fd; border-top: none; overflow: hidden;\">\n<div style=\"background: #f0f9ff; padding: 14px 20px; border-bottom: 1px solid #bae6fd;\">\n<p style=\"font-size: 15px; font-weight: bold; color: #0369a1; margin: 0;\">Q3 \u2014 How does Korean KFDA validate the IBM ophthalmic container&#8217;s dropper cap engagement across all cavities?<\/p>\n<\/div>\n<div style=\"padding: 16px 20px;\">\n<p style=\"font-size: 15px; color: #374151; margin: 0; line-height: 1.7;\">Den koreanske KFDA-kvalificering af farmaceutiske beholdere til oftalmisk dr\u00e5beh\u00e6ttep\u00e5s\u00e6tning valideres gennem tre dokumenterede tests i beholderens tekniske fil. For det f\u00f8rste, dimensionsoverensstemmelse: alle hulrum skal demonstrere halsens ydre diameter inden for \u00b10,05 mm specifikationen - verificeret ved at m\u00e5le 30 beholdere fra hvert hulrum p\u00e5 tv\u00e6rs af 3 produktionsbatches (90 m\u00e5linger pr. hulrum i alt) og bekr\u00e6fte, at alle m\u00e5linger er inden for specifikationen uden afvigelser. For det andet, funktionel dr\u00e5beh\u00e6ttep\u00e5s\u00e6tningstest: 200 beholdere fyldes med destilleret vand, forsegles med den specificerede koreanske dr\u00e5beh\u00e6tte og testes for: (a) h\u00e6ttefastholdelse under 10N aksial tr\u00e6kkraft (simulering af koreansk farmaceuth\u00e5ndtering); (b) h\u00e6ttefjerningskraft inden for specifikationsomr\u00e5det (ikke s\u00e5 t\u00e6t, at patient\u00e5bning kr\u00e6ver overdreven kraft); (c) dr\u00e5bevolumen i dr\u00e5be\u00e5bningen 25-35 \u03bcl pr. dr\u00e5be som specificeret i det koreanske farmaceutiske formuleringskrav. For det tredje, induktionsforseglingens integritet (hvis relevant): beholdere forseglet med induktionsfolie testes i henhold til ASTM F2096 bobletest, hvilket bekr\u00e6fter hermetisk forsegling p\u00e5 tv\u00e6rs af 100% af de testede enheder. Korea Ever-Power leverer resultater af funktionel indgrebstest af dr\u00e5beh\u00e6tter f\u00f8r levering fra produktionstesten som en del af standarddokumentationspakken \u2014 QA-teams fra koreanske farmaceutiske m\u00e6rker kan bruge disse resultater som funktionelle testdata for den f\u00f8rste batch i deres tekniske fil til kvalifikation af KFDA-containere, hvilket reducerer den tid, det tager at udarbejde kvalifikationsdokumentationen efter maskininstallation.<\/p>\n<\/div>\n<\/div>\n<div style=\"border: 1px solid #bae6fd; border-top: none; overflow: hidden;\">\n<div style=\"background: #f0f9ff; padding: 14px 20px; border-bottom: 1px solid #bae6fd;\">\n<p style=\"font-size: 15px; font-weight: bold; color: #0369a1; margin: 0;\">Q4 \u2014 Hvad for\u00e5rsager fejl i fastholdelsen af \u200b\u200bdr\u00e5beh\u00e6tten i koreanske oftalmiske IBM-beholdere, og hvordan afhj\u00e6lpes det?<\/p>\n<\/div>\n<div style=\"padding: 16px 20px;\">\n<p style=\"font-size: 15px; color: #374151; margin: 0; line-height: 1.7;\">Korean ophthalmic IBM container dropper cap retention failure \u2014 where the dropper cap separates from the bottle during Korean pharmacy dispensing handling or Korean patient use \u2014 has two root causes from the IBM container side. First, neck OD below specification minimum: if the IBM container neck OD is below 12.95 mm (13.00 mm nominal minus 0.05 mm tolerance minimum), the dropper cap&#8217;s retention bead does not engage the neck flange with sufficient interference \u2014 the bead slides over the flange without snapping into the retention groove, producing a container that appears capped but releases under minor handling force. Diagnostic: measure all cavities&#8217; neck OD. If specific cavities are consistently below 12.95 mm, the problem is the injection mould neck insert for those cavities \u2014 either dimensional error in the insert or wear in the insert after extended production. Corrective action: regrind or replace the undersized neck cavity insert. Second, neck flange profile insufficiently defined: if the injection mould&#8217;s neck insert flange radius or flange height is below specification \u2014 typically from tool wear after 2\u20133 million cycles in a high-production ophthalmic mould \u2014 the dropper cap bead has no sharp flange edge to engage against, producing low retention force even when neck OD is within specification. Diagnostic: visual inspection of the neck flange profile under 10\u00d7 magnification, comparing to the original mould drawing. Corrective action: neck insert regrind to restore flange sharpness (possible 2\u20133 times before insert replacement is required) or neck insert replacement. Korea Ever-Power&#8217;s mould service team provides neck insert inspection and regrind services for Korean ophthalmic IBM moulds under the machine&#8217;s standard service contract.<\/p>\n<\/div>\n<\/div>\n<div style=\"border: 1px solid #bae6fd; border-top: none; overflow: hidden;\">\n<div style=\"background: #f0f9ff; padding: 14px 20px; border-bottom: 1px solid #bae6fd;\">\n<p style=\"font-size: 15px; font-weight: bold; color: #0369a1; margin: 0;\">Q5 \u2014 Hvor mange ZQ110-maskiner skal en koreansk oftalmisk kontraktpakker bruge for at producere 300 millioner beholdere om \u00e5ret?<\/p>\n<\/div>\n<div style=\"padding: 16px 20px;\">\n<p style=\"font-size: 15px; color: #374151; margin: 0; line-height: 1.7;\">A Korean ophthalmic contract packager targeting 300 million 10 ml containers per year on ZQ110 machines (24 cavities, approximately 19,000 bottles per hour at 88% efficiency, approximately 66.5M containers per Korean two-shift year per machine) needs: 300M \u00f7 66.5M \u2248 4.5 machines \u2014 in practice, 5 ZQ110 machines at 90% of capacity, or 4 ZQ110 machines at 113% of capacity (impossible without a third Korean shift). The practical recommendation for a 300M unit annual requirement on ZQ110 is 5 machines, giving 332.5M annual capacity at 90% utilisation \u2014 10.8% headroom for unscheduled maintenance and demand growth. Five ZQ110 machines also require 5 Korean KFDA machine qualifications. An alternative \u2014 and commercially more efficient \u2014 approach for a 300M annual target is 4 ZQ135 machines: 4 \u00d7 83.2M = 332.8M annual capacity at 90% utilisation, with the same 5 million units headroom but only 4 KFDA machine qualifications (saving one qualification cycle). Korea Ever-Power&#8217;s application engineering team runs these comparative machine count analyses for Korean ophthalmic contract packaging facilities evaluating total cost of ownership, KFDA qualification cost and production flexibility between multiple ZQ110 and fewer ZQ135 configurations.<\/p>\n<\/div>\n<\/div>\n<div style=\"border: 1px solid #bae6fd; border-radius: 0 0 8px 8px; overflow: hidden;\">\n<div style=\"background: #f0f9ff; padding: 14px 20px; border-bottom: 1px solid #bae6fd;\">\n<p style=\"font-size: 15px; font-weight: bold; color: #0369a1; margin: 0;\">Q6 \u2014 Kan koreanske oftalmiske IBM-beholdere produceres i pigmenteret (ravfarvet) HDPE til UV-f\u00f8lsomme formuleringer?<\/p>\n<\/div>\n<div style=\"padding: 16px 20px;\">\n<p style=\"font-size: 15px; color: #374151; margin: 0; line-height: 1.7;\">Yes, but pigmented Korean ophthalmic IBM containers require additional qualification steps versus natural HDPE ophthalmic containers. Amber HDPE for Korean ophthalmic IBM uses iron oxide-based amber masterbatch at 0.3\u20130.8% LDR in HDPE \u2014 iron oxide is on the Korean KFDA positive list for pharmaceutical packaging materials as an approved colourant. The pigment addition affects: extractables profile (additional extractables testing required for the pigmented grade versus natural HDPE \u2014 the amber masterbatch carrier resin and dispersion additives must be evaluated for Korean KFDA extractables compliance separately from the base HDPE resin); body wall translucency (amber pigment reduces visible light transmission further than natural HDPE at the same wall thickness, which is acceptable for UV-sensitive Korean ophthalmic formulations that require UV protection but means fill-level inspection must use a lightbox or specific lighting condition); and IBM processing (the masterbatch must be well-dispersed in the HDPE before IBM processing \u2014 poor dispersion creates visible pigment streaks in the amber bottle wall at the thin body panel zone, which is an appearance defect for Korean pharmacy dispensing). Korean ophthalmic pharmaceutical products that specify amber IBM containers typically include photosensitive Korean ophthalmic antibiotic preparations, certain Korean anti-inflammatory ophthalmic drops with UV-degradable active ingredients, and Korean ophthalmic diagnostic agents. The Korean pharmaceutical brand&#8217;s photostability data for the active ingredient (ICH Q1B photostability testing) should confirm whether an amber container is required or whether natural HDPE (which absorbs UV below 320 nm inherently at 0.35 mm wall) provides sufficient UV protection at the Korean ophthalmic product&#8217;s proposed storage conditions.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<p><!-- CTA --><\/p>\n<div style=\"background: linear-gradient(135deg,#03111e 0%,#0369a1 100%); border-radius: 10px; padding: clamp(30px,5vw,50px) clamp(20px,4vw,40px); text-align: center; margin: 56px 0 48px;\">\n<p style=\"font-size: 10px; font-weight: bold; letter-spacing: 2px; text-transform: uppercase; color: #7dd3fc; margin: 0 0 12px;\">Oftalmisk IBM-foresp\u00f8rgsel<\/p>\n<h2 style=\"font-size: clamp(18px,3vw,26px); font-weight: 800; color: #fff; margin: 0 0 14px;\">Planl\u00e6gger produktion af koreanske oftalmiske beholdere med IBM?<\/h2>\n<p style=\"font-size: 15px; color: #bae6fd; max-width: 480px; margin: 0 auto 26px; line-height: 1.65;\">Korea Ever-Power leverer design af 10 ml oftalmiske IBM-st\u00f8beforme, koreansk KFDA-kvalifikationsdokumentation, planl\u00e6gning af renrumsproduktionscelle og maskinudv\u00e6lgelse i ZQ-serien til koreansk oftalmisk farmaceutisk emballage og h\u00e5ndk\u00f8bs-\u00f8jenplejeemballage i alle \u00e5rlige produktionsvolumener.<\/p>\n<p><a style=\"display: inline-block; background: #f97316; color: #fff; padding: 14px 36px; border-radius: 6px; text-decoration: none; font-weight: bold; font-size: 15px;\" href=\"https:\/\/isbm-blow-molding.com\/da\/contact-us\/\">Anmod om oftalmologisk IBM-konsultation<\/a><\/p>\n<\/div>\n<p><!-- RELATED RESOURCES --><\/p>\n<section style=\"margin-bottom: 56px;\">\n<p style=\"font-size: 10.5px; font-weight: bold; letter-spacing: 2px; text-transform: uppercase; color: #0369a1; margin-bottom: 16px;\">Relaterede ressourcer<\/p>\n<div style=\"display: flex; flex-wrap: wrap; gap: 16px;\">\n<div style=\"background: #fff; border: 1.5px solid #bae6fd; border-top: 4px solid #0369a1; border-radius: 8px; padding: 18px 20px;\"><span style=\"display: block; font-size: 9px; font-weight: bold; color: #f97316; letter-spacing: 1.5px; text-transform: uppercase; margin-bottom: 8px;\">Mellemstor oftalmisk IBM<\/span><br \/>\n<span style=\"display: block; font-size: 15px; font-weight: bold; color: #1e3a8a; margin-bottom: 8px; line-height: 1.3;\">EP-ZQ80 spr\u00f8jtest\u00f8bemaskine<\/span><br \/>\n<span style=\"display: block; font-size: 13px; color: #6b7280; line-height: 1.55;\">800 KN \u00b7 20 hulrum ved 10 ml oftalmisk \u00b7 Vinkeldeler + dobbelt hydraulisk standard \u00b7 ~55 millioner koreanske oftalmiske beholdere pr. koreansk toholds\u00e5r.<\/span><\/div>\n<p>&nbsp;<\/p>\n<div style=\"background: #fff; border: 1.5px solid #bae6fd; border-top: 4px solid #0369a1; border-radius: 8px; padding: 18px 20px;\"><span style=\"display: block; font-size: 9px; font-weight: bold; color: #f97316; letter-spacing: 1.5px; text-transform: uppercase; margin-bottom: 8px;\">Megaskala oftalmisk IBM<\/span><br \/>\n<span style=\"display: block; font-size: 15px; font-weight: bold; color: #1e3a8a; margin-bottom: 8px; line-height: 1.3;\">EP-ZQ135 spr\u00f8jtest\u00f8bemaskine<\/span><br \/>\n<span style=\"display: block; font-size: 13px; color: #6b7280; line-height: 1.55;\">1.350 KN \u00b7 30 hulrum ved 10 ml oftalmisk \u00b7 6+N cylinderzoner \u00b7 37+37 KW \u00b7 ~83 millioner koreanske oftalmiske beholdere pr. \u00e5r \u2014 skala for den koreanske nationale hospitalsforsyningsk\u00e6de.<\/span><\/div>\n<p>&nbsp;<\/p>\n<div style=\"background: #fff; border: 1.5px solid #bae6fd; border-top: 4px solid #0369a1; border-radius: 8px; padding: 18px 20px;\"><span style=\"display: block; font-size: 9px; font-weight: bold; color: #f97316; letter-spacing: 1.5px; text-transform: uppercase; margin-bottom: 8px;\">Materialevejledning<\/span><br \/>\n<span style=\"display: block; font-size: 15px; font-weight: bold; color: #1e3a8a; margin-bottom: 8px; line-height: 1.3;\">HDPE-spr\u00f8jtest\u00f8bning: Komplet procesvejledning<\/span><br \/>\n<span style=\"display: block; font-size: 13px; color: #6b7280; line-height: 1.55;\">Fuld HDPE IBM-bearbejdningsvejledning \u2014 valg af kvalitet (MI 0,3-0,8), ops\u00e6tning af t\u00f8ndetemperatur, specifikation af v\u00e6gtykkelse og valg af ZQ-serie til farmaceutisk og husholdningskemikalie-IBM.<\/span><\/div>\n<p>&nbsp;<\/p>\n<\/div>\n<\/section>\n<p>&nbsp;<\/p>\n<footer style=\"text-align: center; padding: 32px 0 24px; border-top: 1px solid #e5e7eb;\">\n<p style=\"font-size: 12px; color: #9ca3af; margin: 0;\">Redakt\u00f8r: Cxm<\/p>\n<\/footer>\n<p>&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>Ophthalmic IBM \u00b7 Eye Drop Container \u00b7 Korean KFDA \u00b7 Korea Ever-Power HDPE Eye Drop Bottle IBM: Korean Production Guide Korean 10 ml HDPE ophthalmic containers are the highest-volume pharmaceutical IBM format in Korea and one of the most technically demanding: dropper cap engagement precision at \u00b10.05 mm, fill-level transparency at 0.30\u20130.40 mm body wall, [&hellip;]<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[26],"tags":[],"class_list":["post-1044","post","type-post","status-publish","format-standard","hentry","category-application-of-isbm"],"_links":{"self":[{"href":"https:\/\/isbm-blow-molding.com\/da\/wp-json\/wp\/v2\/posts\/1044","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/isbm-blow-molding.com\/da\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/isbm-blow-molding.com\/da\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/isbm-blow-molding.com\/da\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/isbm-blow-molding.com\/da\/wp-json\/wp\/v2\/comments?post=1044"}],"version-history":[{"count":1,"href":"https:\/\/isbm-blow-molding.com\/da\/wp-json\/wp\/v2\/posts\/1044\/revisions"}],"predecessor-version":[{"id":1046,"href":"https:\/\/isbm-blow-molding.com\/da\/wp-json\/wp\/v2\/posts\/1044\/revisions\/1046"}],"wp:attachment":[{"href":"https:\/\/isbm-blow-molding.com\/da\/wp-json\/wp\/v2\/media?parent=1044"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/isbm-blow-molding.com\/da\/wp-json\/wp\/v2\/categories?post=1044"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/isbm-blow-molding.com\/da\/wp-json\/wp\/v2\/tags?post=1044"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}